Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
26 Sep 2016
Transparency notification
Read More
19 Sep 2016
UCB receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) AutoClicks® Prefilled Pen
Read More
18 Sep 2016
Results from phase 3 Frame study of romosozumab showed significant reductions in both new vertebral and clinical fractures in postmenopausal women with osteoporosis
Read More
16 Sep 2016
Transparency notification
Read More
16 Sep 2016
Transparency notification
Read More
8 Sep 2016
Transparency notifications
Read More
6 Sep 2016
UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting
Read More
6 Sep 2016
UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting
Read More
18 Aug 2016
Transparency notification
Read More
14 Aug 2016
U.S. District Court confirms validity of patent for UCB's Vimpat®
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
37
Page
38
Page
39
Page
40
Current page
41
Page
42
Page
43
Page
44
Page
45
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss